Refractory Mature B-Cell Non-Hodgkin Lymphoma

general

5

Centers

1

Active Trials

$1.6B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Refractory Mature B-Cell Non-Hodgkin Lymphoma(5)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
2
NCI Comprehensive
3
4
NCI Comprehensive
5
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →